Find clinical trials for Lung Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near New York, NY, USA:
of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical str...
Phase 2
New York, New York, United States
and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...
Phase 2
Lake Success, New York, United States and 64 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
New York, New York, United States and 83 other locations
with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung ...
Phase 2
New York, New York, United States and 8 other locations
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
New York, New York, United States and 15 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
New York, New York, United States and 43 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Bronx, New York, United States and 205 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
New York, New York, United States and 11 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Hackensack, New Jersey, United States and 139 other locations
metastatic NSCLC with an EGFR mutation. Both drugs work to target cancer cells with an EGFR mutation, and this targeting action could stop o...
Phase 2
New York, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal